Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 01/02/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Dayonix Pharma expands operations into U.S marketplace
 
(January 02, 2018)
Dayonix Pharma expands operations into U.S marketplace

Dayonix Pharma, a nutraceutical, cosmetic and generic pharmaceuticals company that focuses on improving general health and prevention of specific ailments - rather than simply treating the symptoms - through the use of dietary supplements, is expanding its operations into the U.S. marketplace.

Dayonix Pharma's products vary from vitamins and minerals formulated for different age groups - ranging from newborns to grandparents - to healthcare supplements made of plant extracts that combine amino and fatty acids, minerals and vitamins. Each product intends to help prevent diseases for individuals at risk of deficiencies, as well as improve general health and wellbeing.

Dayonix Pharma already sells products throughout Europe, South Africa and other countries, and is now bringing its diverse line of products and “Live Happily" voice to the U.S.



Dayonix Pharma, based in Germany, prides itself on continuous innovation through research at its Portugal and German labs. Its most popular health supplements include Liverex, Irofix, Respigen, Crono and Viatex. These products have scientific studies backing their abilities to help improve or maintain several body systems, including liver function, the pancreatic system, blood circulation, respiratory, coronary circulation and the reproductive system.

Liverex, for example, detoxifies the liver to promote a healthy metabolism and improved digestion. Liverex does this using the nutrient choline, the antioxidant glutathione and folic acid precursor quatrefolic®.

Dayonix Pharma creates different products for different age groups. Its products for children have fruity flavors kids love, such as peach, lemon and strawberry. The most popular Kids products are Kidssi Sleep, Kidssi Appetite and Kidssi Growth, used to improve sleep, appetite and growth in children, respectively.

“Babies, children and adults have different dietary requirements and need different amounts of nutrients, including herbal extracts, to properly nourish the body," Dayonix Pharma Vice President Ricardo Correia said. “Dayonix Pharma aims to serve those who enjoy a healthy lifestyle, both for themselves and for their kids."

Dayonix Pharma works to reduce its impact on the environment, and is conscious of best environmental practices for its surrounding neighborhood, employees and customers. Most of Dayonix Pharma's products are free of sugar, artificial colors, ingredients and gluten, and the labels are all clearly marked and easy to read.

For more information on Dayonix Pharma and its products, visit http://www.dayonixpharma.com.

Read the full story at http://www.prweb.com/releases/2018/01/prweb15045184.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines